Impact of a comprehensive safety program on radiation exposure during catheter ablation of atrial fibrillation: a prospective study

被引:23
作者
Lakkireddy, Dhanunjaya [8 ]
Nadzam, George [2 ]
Verma, Atul [3 ]
Prasad, Subramanya
Ryschon, Kay
Di Biase, Luigi [1 ]
Khan, Mohammed [4 ]
Burkhardt, David [1 ]
Schweikert, Robert [5 ]
Natale, Andrea [1 ,6 ,7 ]
机构
[1] St David Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX 78705 USA
[2] Cleveland Clin Fdn, Cleveland, OH USA
[3] Southlake Reg Hosp, New Market, ON, Canada
[4] Cardiovasc Associates, Elk Grove Village, IL USA
[5] Akron Gen Hosp, Akron, OH USA
[6] Stanford Univ, Palo Alto, CA 94304 USA
[7] Case Western Reserve Univ, Cleveland, OH 44106 USA
[8] Univ Kansas Hosp, Kansas City, KS USA
关键词
Atrial fibrillation; Ablation; Pulmonary vein antral isolation; Radiation; Safety; RADIOFREQUENCY ABLATION; PULMONARY VEIN; SUPRAVENTRICULAR TACHYCARDIA; CARDIAC ELECTROPHYSIOLOGY; FLUOROSCOPY; PATIENT; REDUCTION; PERSONNEL; TIME; RISK;
D O I
10.1007/s10840-008-9316-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary vein antral isolation (PVAI) is an effective treatment for atrial fibrillation and involves prolonged procedure and fluoroscopy times. This study assesses the impact of a comprehensive radiation safety program on patient and operator radiation exposure during PVAI. We evaluated a comprehensive radiation safety program including: (1) verbal reinforcement of previous fluoroscopy times (2) effective collimation (3) minimizing source-intensifier distance and (4) effective lead shield use. Exposure doses in 41 consecutive patients without (group-I, n = 21) and with (group-II, n = 20) the use of radiation safety program were assessed. PVAI was done using intracardiac echo (ICE) guided roving circular mapping catheter. A 3-dimensional mapping system was used in 27% cases for additional guidance. Operator and patient exposure was measured during the PVAI. The age, gender, body mass index and AF duration were similar in both of the groups. The total procedure (166 +/- 56 vs 178 +/- 38 min, p = 0.54) and fluoroscopy times (74 +/- 24 vs 70 +/- 20 min, p = 0.72) were comparable. Group-II had significantly lower dose area product (234 +/- 120 vs 548 +/- 363 Gy cm(2), p = 0.03) compared to group-I. The mean operator exposure was reduced by half and mean patient peak skin dose by three to ten times with comprehensive radiation safety program. None of the patients were noted to have radiation related skin injuries. Additional lifetime cancer risk was significantly lower in group-II patients (0.08 vs 0.2%, p < 0.001) than group-I. Implementation of a comprehensive radiation safety program described above significantly decreases the radiation exposure to the patient as well as the operator.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 30 条
  • [21] Pappone C, 2000, CIRCULATION, V102, P2619
  • [22] Accurate assessment of patient effective radiation dose and associated detriment risk from radiofrequency catheter ablation procedures
    Perisinakis, K
    Damilakis, J
    Theocharopoulos, N
    Manios, E
    Vardas, P
    Gourtsoyiannis, N
    [J]. CIRCULATION, 2001, 104 (01) : 58 - 62
  • [23] ROSENSTEIN M, 1994, HEALTH PHYS, V67, P88
  • [24] Acute radiation dermatitis following radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia
    Rosenthal, LS
    Beck, TJ
    Williams, J
    Mahesh, M
    Herman, MG
    Dinerman, JL
    Calkins, H
    Lawrence, JH
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (07): : 1834 - 1839
  • [25] Sacher F, 2004, ARCH MAL COEUR VAISS, V97, P949
  • [26] Reduction of radiation exposure time during catheter ablation with the use of pulsed fluoroscopy
    Scanavacca, M
    d'Avila, A
    Velarde, JL
    Reolao, JB
    Sosa, E
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 63 (01) : 71 - 74
  • [27] Pulmonary vein antrum isolation: Intracardiac echocardiography-guided technique
    Verma, A
    Marrouche, NF
    Natale, A
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (11) : 1335 - 1340
  • [28] Why atrial fibrillation ablation should be considered first-line therapy for some patients
    Verma, A
    Natale, A
    [J]. CIRCULATION, 2005, 112 (08) : 1214 - 1222
  • [29] Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation - A randomized trial
    Wazni, OM
    Marrouche, NF
    Martin, DO
    Verma, A
    Bhargava, M
    Saliba, W
    Bash, D
    Schweikert, R
    Brachmann, J
    Gunther, J
    Gutleben, K
    Pisano, E
    Potenza, D
    Fanelli, R
    Raviele, A
    Themistoclakis, S
    Rossillo, A
    Bonso, A
    Natale, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (21): : 2634 - 2640
  • [30] Reduction of radiation exposure in the cardiac electrophysiology laboratory
    Wittkampf, FHM
    Wever, EFD
    Vos, K
    Geleijns, J
    Schalij, MJ
    Van der Tol, J
    De Medina, EOR
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11): : 1638 - 1644